Peter Mohr
Impact in
- Oncology top 1%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 74
- Cutaneous Melanoma Detection and Management 37
- Cancer Immunotherapy and Biomarkers 27
- CAR-T cell therapy research 24
- Polyomavirus and related diseases 7
-
- Melanoma and MAPK Pathways 26
- Co-authors
- Dirk Schadendorf (34 shared papers)Axel Hauschild (34 shared papers)Claus Garbe (24 shared papers)Jochen Utikal (16 shared papers)Peter Hersey (5 shared papers)Uwe Trefzer (12 shared papers)Reinhard Dummer (9 shared papers)Jessica C. Hassel (12 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Annals of Oncology (18 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (11 papers)Melanoma Research (8 papers)European Journal of Cancer (7 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Peter Mohr
104 papers receiving 3.7k citations
Peter Mohr's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 2.2k
- Immunology 587
- Ophthalmology 218
- Molecular Biology 1.7k
- Dermatology 173
Countries citing papers authored by Peter Mohr
This map shows the geographic impact of Peter Mohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mohr more than expected).
Fields of papers citing papers by Peter Mohr
This network shows the impact of papers produced by Peter Mohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mohr. The network helps show where Peter Mohr may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Mohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group Hit paper breakdown → | 2012 | 1110 |
| 2 | 2004 | 376 | |
| 3 | 2015 | 191 | |
| 4 | 2014 | 151 | |
| 5 | 2003 | 117 | |
| 6 | 2009 | 114 | |
| 7 | 2010 | 110 | |
| 8 | 2009 | 73 | |
| 9 | 2013 | 72 | |
| 10 | Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. | 1999 | 71 |
| 11 | 2001 | 68 | |
| 12 | 2017 | 68 | |
| 13 | 2011 | 67 | |
| 14 | 2019 | 57 | |
| 15 | 2017 | 57 | |
| 16 | 2010 | 56 | |
| 17 | 2015 | 56 | |
| 18 | 2019 | 51 | |
| 19 | 2015 | 46 | |
| 20 | 2006 | 34 |
About Peter Mohr
Peter Mohr is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Dermatology, having authored 114 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (37 papers), Cancer Immunotherapy and Biomarkers (27 papers), Melanoma and MAPK Pathways (26 papers), CAR-T cell therapy research (24 papers), Immunotherapy and Immune Responses (14 papers), Cancer Genomics and Diagnostics (8 papers), Nonmelanoma Skin Cancer Studies (8 papers) and Polyomavirus and related diseases (7 papers). The work is most often cited by research in Oncology (2.2k citations), Immunology (587 citations), Ophthalmology (218 citations), Molecular Biology (1.7k citations) and Dermatology (173 citations). Peter Mohr has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Dirk Schadendorf, Axel Hauschild, Claus Garbe, Jochen Utikal, Peter Hersey, Uwe Trefzer, Reinhard Dummer, Jessica C. Hassel, Caroline Robert and Piotr Rutkowski. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, JDDG Journal der Deutschen Dermatologischen Gesellschaft, Melanoma Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.